United States Biotechnology & Medical Research

Pandion Therapeutics Inc (PAND)

Track

Ticker: PAND Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Becker Daniel J. Non-Executive Director
Transaction date
Purchase
Price
423.36
Quantity 80,625 +26.4%
Value US$961,525
3.2
Becker Daniel J. Non-Executive Director
Transaction date
Purchase
Price
106.05
Quantity 73,318 +18.6%
Value US$4,122,782
3.2
Becker Daniel J. Non-Executive Director
Transaction date
Purchase
Price
217.20
Quantity 73,759 -16.0%
Value US$4,456,987
3.2
Becker Daniel J. Non-Executive Director
Transaction date
Purchase
Price
14.63
Quantity 2,170 +0.1%
Value US$31,747
Mutz Mitchell Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 10,000 +inf%
Value US$180,000
Mutz Mitchell Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 36,111 +1.2%
Value US$649,998
3.1
ROCHE HOLDING LTD Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 36,111 +1.2%
Value US$649,998
2.3
GLAXOSMITHKLINE PLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 361,111 +19.1%
Value US$6,499,998
3.6
Boxer Capital, LLC Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 722,222 +52.1%
Value US$12,999,996
Frail Donald Non-Executive Director
Transaction date
Purchase
Price
18.00
Quantity 10,000 +19.6%
Value US$180,000
Viney Joanne L. See Remarks Officer
Transaction date
Purchase
Price
18.00
Quantity 1,200 +inf%
Value US$21,600
Crane Alan L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 14,000 +20.0%
Value US$252,000
Crane Alan L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 1,248 +1.1%
Value US$22,464
Crane Alan L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 34,863 +1.1%
Value US$627,534
3.2
Becker Daniel J. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 1,000 +inf%
Value US$18,000
3.2
Becker Daniel J. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 722,222 +38.4%
Value US$12,999,996
Stagliano Nancy Non-Executive Director
Transaction date
Purchase
Price
18.00
Quantity 1,000 +inf%
Value US$18,000
Kakkar Rahul Chief Executive Officer Executive Director
Transaction date
Purchase
Price
18.00
Quantity 14,000 +inf%
Value US$252,000
3.4
Carroll Jill Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 361,111 +19.1%
Value US$6,499,998
Fuglesang Christopher Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 722,222 +38.4%
Value US$12,999,996
0.6
Goyal Vikas See Remarks Officer
Transaction date
Purchase
Price
18.00
Quantity 1,450 +1.7%
Value US$26,100
Sundy John Chief Medical Officer Officer
Transaction date
Purchase
Price
18.00
Quantity 2,000 +1.8%
Value US$36,000
Larson Eric D Vice President, Finance Officer
Transaction date
Purchase
Price
18.00
Quantity 600 +2.8%
Value US$10,800
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-11-23 2020-11-19 B Purchase
3.2
Becker Daniel J.
Non-Executive Director
80,625 +26.4%
423.36
US$961,525 		80,625 +26.4% 423.36 US$961,525
2020-11-19 2020-11-18 B Purchase
3.2
Becker Daniel J.
Non-Executive Director
73,318 +18.6%
106.05
US$4,122,782 		73,318 +18.6% 106.05 US$4,122,782
2020-11-19 2020-11-17 B Purchase
3.2
Becker Daniel J.
Non-Executive Director
73,759 -16.0%
217.20
US$4,456,987 		73,759 -16.0% 217.20 US$4,456,987
2020-11-19 2020-11-17 B Purchase
3.2
Becker Daniel J.
Non-Executive Director
2,170 +0.1%
14.63
US$31,747 		2,170 +0.1% 14.63 US$31,747
2020-07-23 2020-07-21 B Purchase
Mutz Mitchell
Non-Executive Director Large shareholder
10,000 +inf%
18.00
US$180,000 		10,000 +inf% 18.00 US$180,000
2020-07-23 2020-07-21 B Purchase
Mutz Mitchell
Non-Executive Director Large shareholder
36,111 +1.2%
18.00
US$649,998 		36,111 +1.2% 18.00 US$649,998
2020-07-23 2020-07-21 B Purchase
3.1
ROCHE HOLDING LTD
Large shareholder
36,111 +1.2%
18.00
US$649,998 		36,111 +1.2% 18.00 US$649,998
2020-07-22 2020-07-21 B Purchase
2.3
GLAXOSMITHKLINE PLC
Non-Executive Director Large shareholder
361,111 +19.1%
18.00
US$6,499,998 		361,111 +19.1% 18.00 US$6,499,998
2020-07-22 2020-07-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
361,111 +25.6%
18.00
US$6,499,998 		361,111 +25.6% 18.00 US$6,499,998
2020-07-21 2020-07-21 B Purchase
3.6
Boxer Capital, LLC
Large shareholder
722,222 +52.1%
18.00
US$12,999,996 		722,222 +52.1% 18.00 US$12,999,996
2020-07-21 2020-07-21 B Purchase
Frail Donald
Non-Executive Director
10,000 +19.6%
18.00
US$180,000 		10,000 +19.6% 18.00 US$180,000
2020-07-21 2020-07-21 B Purchase
Viney Joanne L.

See Remarks

Officer
1,200 +inf%
18.00
US$21,600 		1,200 +inf% 18.00 US$21,600
2020-07-21 2020-07-21 B Purchase
Crane Alan L
Non-Executive Director Large shareholder
14,000 +20.0%
18.00
US$252,000 		14,000 +20.0% 18.00 US$252,000
2020-07-21 2020-07-21 B Purchase
Crane Alan L
Non-Executive Director Large shareholder
1,248 +1.1%
18.00
US$22,464 		1,248 +1.1% 18.00 US$22,464
2020-07-21 2020-07-21 B Purchase
Crane Alan L
Non-Executive Director Large shareholder
34,863 +1.1%
18.00
US$627,534 		34,863 +1.1% 18.00 US$627,534
2020-07-21 2020-07-21 B Purchase
3.2
Becker Daniel J.
Non-Executive Director Large shareholder
1,000 +inf%
18.00
US$18,000 		1,000 +inf% 18.00 US$18,000
2020-07-21 2020-07-21 B Purchase
3.2
Becker Daniel J.
Non-Executive Director Large shareholder
722,222 +38.4%
18.00
US$12,999,996 		722,222 +38.4% 18.00 US$12,999,996
2020-07-21 2020-07-21 B Purchase
Polaris Partners GP VIII, L.L.C.
Large shareholder
1,248 +1.1%
18.00
US$22,464 		1,248 +1.1% 18.00 US$22,464
2020-07-21 2020-07-21 B Purchase
Polaris Partners GP VIII, L.L.C.
Large shareholder
34,863 +1.1%
18.00
US$627,534 		34,863 +1.1% 18.00 US$627,534
2020-07-21 2020-07-21 B Purchase
Stagliano Nancy
Non-Executive Director
1,000 +inf%
18.00
US$18,000 		1,000 +inf% 18.00 US$18,000
2020-07-21 2020-07-21 B Purchase
Kakkar Rahul

Chief Executive Officer

Executive Director
14,000 +inf%
18.00
US$252,000 		14,000 +inf% 18.00 US$252,000
2020-07-21 2020-07-21 B Purchase
3.4
Carroll Jill
Non-Executive Director Large shareholder
361,111 +19.1%
18.00
US$6,499,998 		361,111 +19.1% 18.00 US$6,499,998
2020-07-21 2020-07-21 B Purchase
Fuglesang Christopher
Non-Executive Director Large shareholder
722,222 +38.4%
18.00
US$12,999,996 		722,222 +38.4% 18.00 US$12,999,996
2020-07-21 2020-07-21 B Purchase
0.6
Goyal Vikas

See Remarks

Officer
1,450 +1.7%
18.00
US$26,100 		1,450 +1.7% 18.00 US$26,100
2020-07-21 2020-07-21 B Purchase
Sundy John

Chief Medical Officer

Officer
2,000 +1.8%
18.00
US$36,000 		2,000 +1.8% 18.00 US$36,000
2020-07-21 2020-07-21 B Purchase
Larson Eric D

Vice President, Finance

Officer
600 +2.8%
18.00
US$10,800 		600 +2.8% 18.00 US$10,800
Explore more

More insider trading research around Pandion Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America